Skip to main content
. 2012 Apr 16;12:94. doi: 10.1186/1472-6963-12-94

Table 1.

Quality indicators, expected health gain, and payment for performance in 2004

Quality Indicator label Indicator Level of evidence1 Payment thresholds (%) Payment range2 Maximum payment (£) Marginal payment (£)3 E-reporting rate (%) 20054 Maximum lives saved (n) Achievable lives saved (n) Incentivised lives saved (n) Maximum QALYs gained (n) Achievable QALYs gained (n) Incentivised QALYs gained (n)
1 DM 18 c 25-85 60 225 3.75 13 4.1 3.6 3.0

2 CHD 12 c 25-85 60 525 8.75 11 4 3.6 3.0

3 BP 5 rct 25-70 45 4200 93.33 5 3.1 2.9 2.1 561 533 373

4 CHD 10 rct 25-50 25 525 21.00 25 2.9 2.2 1.1 427 320 160

5 Stroke 10 c 25-85 60 150 2.50 13 1.8 1.6 1.4

6 DM 6 rct 25-50 25 1200 48.00 12 1.7 1.5 0.7

8 COPD 8 c 25-85 60 450 7.50 11 1.6 1.4 1.2

9 CHD 9 rct 25-90 65 525 8.08 4 1.6 1.5 1.4 2 2 2

11 CHD 8 rct 25-60 35 1200 34.29 10 1 0.9 0.5

12 Stroke9 rct 25-90 65 300 4.62 5 1 1.0 0.9 11 10 9

13 DM 12 c 25-55 30 1275 42.50 8 0.9 0.8 0.5

14 LVD 3 rct 25-70 45 750 16.67 7 0.8 0.7 0.5 5 5 3

15 CHD 6 rct 25-70 45 1425 31.67 4 0.7 0.7 0.5

17 Asthma 5 c 25-70 45 450 10.00 3 0.6 0.6 0.4

18 DM 7 c 25-85 60 825 13.75 6 0.4 0.4 0.3

19 BP 3 c 25-90 65 750 11.54 1 0.3 0.3 0.3

20 DM 15 rct 25-70 45 225 5.00 6 0.2 0.2 0.1 17 16 11

21 COPD 5 rct 25-90 65 450 6.92 2 0.2 0.2 0.2

22 DM 4 c 25-90 65 375 5.77 3 0.1 0.1 0.1

23 CHD 4 c 25-90 65 300 4.62 3 0.1 0.1 0.1

24 CHD 11 rct 25-70 45 525 11.67 7 0.1 0.1 0.1 2 2 1

25 Stroke4 c 25-70 45 150 3.33 4 0.1 0.1 0.1

27 CS1 c 25-80 55 825 15.00 5 71 67 54

28 DM8 c 25-90 65 375 5.77 6 115 108 97

All data for an average practice of 6411 patients, all figures rounded to whole numbers (except lives saved and marginal payment)

1 rct = randomised controlled trial, c = cohort. 2 % range of achievement between minimum and maximum payments

3 £ incentive gained for a 1% increase in performance within payment range. 4 E-reporting = exception reporting